Updated:
Wuhan Jianmin Pharmaceutical Group Co.
Wuhan Jianmin Pharmaceutical Group Co. is a pharmaceutical firm with offices in Beijing, Wuhan, Shenzhen, and San Jose.
Wuhan Jianmin Pharmaceutical Group Co.
Wuhan Jianmin Pharmaceutical Group Co. is a pharmaceutical enterprise with a headquarter presence in Beijing and additional offices in Wuhan, Shenzhen, and San Jose. The firm's exact founding year and ownership structure are not publicly documented. The group's core business involves the manufacturing and marketing of pharmaceutical products. Its operations span China's domestic market and extend to international markets through its San Jose office. The company likely engages in drug development, production, and distribution across therapeutic categories. The firm maintains a multi-city operational footprint across China and a US office in San Jose. No team size, AUM, or investment activity data is publicly available for this entity. The firm's structural differentiator remains unclear due to limited public information. Its multi-city presence across China and inclusion of a US location may indicate a regional expansion strategy or supply chain operations.
General information
Firm type
other
Year founded
—
AUM
Undisclosed
Location
Region
Asia
Country
China
City
Beijing
Corporate office
Beijing, China
Additional offices
Wuhan · Shenzhen · San Jose
Sector focus
Frequently asked questions
What is the primary business of Wuhan Jianmin Pharmaceutical Group Co.?
Wuhan Jianmin Pharmaceutical Group Co. is a pharmaceutical firm engaged in the manufacturing and marketing of pharmaceutical products. Its operations include drug development, production, and distribution across China and international markets.
Where is the headquarters of Wuhan Jianmin Pharmaceutical Group located?
The firm's headquarters is in Beijing, China. It also maintains offices in Wuhan, Shenzhen, and San Jose.
Does Wuhan Jianmin Pharmaceutical Group have international operations?
Yes, the group has an office in San Jose, California, indicating a presence in the US market. The extent of its international operations is not publicly detailed.
What is the ownership structure of Wuhan Jianmin Pharmaceutical Group?
The ownership structure of Wuhan Jianmin Pharmaceutical Group Co. is not publicly disclosed. It may be a privately held or publicly traded entity, but no documentation confirms either status.
What investment stages does Wuhan Jianmin Pharmaceutical Group target?
The firm appears to be a pharmaceutical operating company rather than an investment vehicle. No information is available on any investment activities or target stages.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: